Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term efficacy and safety of low-dose ticagrelor in acute coronary syndrome patients with high bleeding risk
KCT0004640Phase 4Completed
- Sponsor
- Pusan National University Hospital
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in acute coronary syndrome (ACS), sponsored by Pusan National University Hospital. Started May 2017; status: completed.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on KCT0004640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004640.